ABU DHABI, UAE — Thrombolytic treatment with recombinant human pro-urokinase was non-inferior to alteplase in achieving an excellent functional outcome in acute ischemic stroke but showed a ...

Thrombolytic drugs are the main treatment for stroke, but they have often not been recommended for people who have an aneurysm in their brains that has not ruptured. A new study (“Risk of Aneurysm ...

For patients with acute ischemic stroke due to a large-vessel occlusion (LVO), administering intra-arterial thrombolytics after successful endovascular thrombectomy does not significantly improve ...

GREEN BAY, Wis. (WFRV) – Before heading to her appointment, Elaine Hazuka called her children because something felt off. “Before I left, I felt uneasy,” Hazuca said. Although she wasn’t feeling well, ...

The province announced $2.5 million on Thursday to equip advanced care paramedics with pre-hospital thrombolytics for cardiac patients.

Two randomized trials found that intra-arterial urokinase and tenecteplase did not improve functional outcomes after mechanical thrombectomy in selected stroke patients. However, these results do not ...

The province is giving some paramedics more tools to help treat heart attacks. Advanced care paramedics will now be able to use thrombolytics, which are also known as "clot-busters." Officials say the ...

TGD001 is being developed to offer patients with clotting disorders a faster, safer and more effective treatment than today’s standard of care – saving lives and reducing disability Following the ...

Antithrombotic therapy aims to prevent blood clots and the serious damage they can cause. Types include anticoagulants like heparin, antiplatelets like aspirin, and emergency thrombolytics. Thrombosis ...

A new study finds that a significant portion of older adults with mild cognitive impairment or dementia develop new cardiovascular diagnoses each year that may require treatment with anticoagulants or ...

Revascularization of ischemic tissue and rescue of a still-viable penumbra are valid therapeutic goals, but the literature in support of thrombolytics in acute ischemic stroke should not be ...

These words uttered in 1901 relate directly to studies of thrombolytics for AMI. In GISSI-1 and 2 other major thrombolysis trials, the investigators did not require an informed consent of the patients ...